CORTEX PHARMACEUTIC Valuation

PHXDelisted Stock  USD 4.35  0.00  0.00%   
At this time, the firm appears to be overvalued. CORTEX PHARMACEUTIC shows a prevailing Real Value of $3.46 per share. The current price of the firm is $4.35. Our model approximates the value of CORTEX PHARMACEUTIC from analyzing the firm fundamentals such as return on equity of 0.0555, and Profit Margin of 0.19 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
4.35
Please note that CORTEX PHARMACEUTIC's price fluctuation is unstable at this time. Calculation of the real value of CORTEX PHARMACEUTIC is based on 3 months time horizon. Increasing CORTEX PHARMACEUTIC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CORTEX PHARMACEUTIC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CORTEX Stock. However, CORTEX PHARMACEUTIC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.35 Real  3.46 Hype  4.35 Naive  4.34
The intrinsic value of CORTEX PHARMACEUTIC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CORTEX PHARMACEUTIC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
3.46
Real Value
7.00
Upside
Estimating the potential upside or downside of CORTEX PHARMACEUTIC helps investors to forecast how CORTEX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CORTEX PHARMACEUTIC more accurately as focusing exclusively on CORTEX PHARMACEUTIC's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.304.334.35
Details
Hype
Prediction
LowEstimatedHigh
0.814.357.89
Details
Potential
Annual Dividend
LowForecastedHigh
0.080.080.09
Details

CORTEX PHARMACEUTIC Total Value Analysis

CORTEX PHARMACEUTIC is at this time forecasted to have company total value of 182.81 M with market capitalization of 164.96 M, debt of 30.2 M, and cash on hands of 3.4 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the CORTEX PHARMACEUTIC fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
182.81 M
164.96 M
30.2 M
3.4 M

CORTEX PHARMACEUTIC Investor Information

About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. CORTEX PHARMACEUTIC last dividend was issued on the 20th of May 2025. The entity had 2:1 split on the 9th of October 2014. Based on the measurements of operating efficiency obtained from CORTEX PHARMACEUTIC's historical financial statements, CORTEX PHARMACEUTIC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.

CORTEX PHARMACEUTIC Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CORTEX PHARMACEUTIC has an asset utilization ratio of 20.91 percent. This suggests that the Company is making $0.21 for each dollar of assets. An increasing asset utilization means that CORTEX PHARMACEUTIC is more efficient with each dollar of assets it utilizes for everyday operations.

CORTEX PHARMACEUTIC Ownership Allocation

CORTEX PHARMACEUTIC holds a total of 37.92 Million outstanding shares. Over half of CORTEX PHARMACEUTIC's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Therefore, these institutions are subject to different rules and regulations than regular investors in CORTEX PHARMACEUTIC. Please watch out for any change in the institutional holdings of CORTEX PHARMACEUTIC as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

CORTEX PHARMACEUTIC Profitability Analysis

The company reported the last year's revenue of 34.27 M. Total Income to common stockholders was 2.32 M with profit before taxes, overhead, and interest of 30.11 M.

CORTEX PHARMACEUTIC Past Distributions to stockholders

About CORTEX PHARMACEUTIC Valuation

Our relative valuation model uses a comparative analysis of CORTEX PHARMACEUTIC. We calculate exposure to CORTEX PHARMACEUTIC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CORTEX PHARMACEUTIC's related companies.
PHX Minerals Inc. operates as a natural gas and oil mineral company in the United States. PHX Minerals Inc. was founded in 1926 and is based in Oklahoma City, Oklahoma. Phx Minerals operates under Oil Gas EP classification in the United States and is traded on New York Stock Exchange. It employs 20 people.

8 Steps to conduct CORTEX PHARMACEUTIC's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CORTEX PHARMACEUTIC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CORTEX PHARMACEUTIC's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain CORTEX PHARMACEUTIC's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine CORTEX PHARMACEUTIC's revenue streams: Identify CORTEX PHARMACEUTIC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research CORTEX PHARMACEUTIC's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish CORTEX PHARMACEUTIC's growth potential: Evaluate CORTEX PHARMACEUTIC's management, business model, and growth potential.
  • Determine CORTEX PHARMACEUTIC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CORTEX PHARMACEUTIC's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in CORTEX Stock

If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios